Latest Breaking News On - United kingdom based microbiotica - Page 1 : comparemela.com

Competition is heating up in the microbiome niche as UK-based biotech Microbiotica raised €60M (£50M) in a Series B round to advance two candidates designed to treat cancer and ulcerative colitis.

Roche genentechEligo biosciencesSwitzerland ferring pharmaceuticalsUnited kingdom based microbioticaFlerie investChina based tencentIsabelle de cremouxManaging partnerSeventure partnersSeres therapeuticsFinch therapeuticsFerring pharmaceuticalsMaat pharma